LifeSciences BC Blakes Breakfast Speaking Event on Digital Health featuring McKesson and Equicare Health
October 6, 2016
LifeSciences BC is pleased to feature McKesson and Equicare Health at our Blakes Breakfast Speaking Event on Digital Health. Where they will explore advances and opportunities, designed to improve patient outcomes.
Speakers:
Ashish Sant,
General Manager, Radiology Solutions,
McKesson
Betsabeh Madani,
VP of Strategy and Business Development, Equicare Health
Malcolm Wright
VP of Product Management, Equicare Health
Event Details
Date: Thursday, October 6
Time: 7:30 - 8:00 AM- Registration and hot breakfast
8:00 - 9:00 AM - Presentations
9:00 - 9:30 AM - Networking opportunity
Location: Terminal City Club - 837 West Hastings Street, Vancouver
Hosted for its second year, LifeSciences BC's Access to Innovation Conference will bring together health and life sciences stakeholders to present, discuss and deliver meaningful ways to culitivate collaboration, develop and deliver innovation, while improving outcomes and saving healthcare cost.
Keynote Speakers: Hon. Dr. Andrew Wilkinson, Minister of Advanced Education & Hon. Amrik Virk, Minister of Technology, Innovation & Citizens' Services
Confirmed Presenters: Dr. Jane Aubin, Dr. Robert McMaster, Dr. Brendan Byrne, Dr. David Castle, Dr. Heather Davidson, Dr. Bettina Hamelin, Dr. Simon Sutcliffe, Dr. Gavin Stuart, Dr. Sue Collier and Dr. Leslie Alexander, CEO & President, Life Sciences Washington
Aequus Obtains Ontario Provincial Listing for PrVistitan™
Vancouver, BC., September 29, 2016 - Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that it has successfully obtained provincial formulary coverage from the Ontario Drug Benefit Program for PrVistitanTM (bimatoprost 0.03% w/v, ophthalmic solution).
Arbutus to Present HBV Data at the 2016 AASLD Liver Meeting
VANCOUVER, British Columbia and DOYLESTOWN, Pa., Oct. 01, 2016 (GLOBE NEWSWIRE) - Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading hepatitis B virus (HBV) therapeutic solutions company, today announced presentation of data at the 2016 American Association for the Study of Liver Diseases (AASLD) Liver Meeting being held on November 11 - 15, 2016, at the John B. Hynes Veterans Memorial Convention Center, Boston.
Arbutus Recognizes Liver Cancer Awareness Month with Grant to Support the Hepatitis B Foundation's Patient Storytelling Campaign
VANCOUVER, British Columbia and DOYLESTOWN, Pa., Oct. 03, 2016 (GLOBE NEWSWIRE) - Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced a partnership with the Hepatitis B Foundation to support the Patient Storytelling Campaign.
Aquinox Announces Appointment of Dr. Barbara Troupin as Chief Medical Officer
VANCOUVER, British Columbia, Oct. 03, 2016 (GLOBE NEWSWIRE) - Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, is pleased to announce the appointment of Dr. Barbara Troupin, M.D. as Chief Medical Officer and Vice President, Clinical Development.
Gov't streams £220m into commercialising innovations
October 3, 2016 | by Selina McKee | The government has announced that life sciences and university sectors will receive a "package of support" including a cash stream of £220 million to help translate technology breakthroughs into commercial successes.
AbbVie opens first phase of $320M site in Singapore
September 29, 2016 | by Eric Palmer | Just two years after initial work on a massive dual-focus manufacturing facility in Asia, AbbVie says the first phase is good to go.
2016 Nobel Prize in Physiology or Medicine presented to Yoshinori Ohsumi
for his discoveries of mechanisms for autophagy
Dr. Yoshinori Ohsumi, Recipient of the Canada Gairdner International Award 2015 and Genome BC and LifeSciences BC Breakfast Speaker, has won this year's Noble Prize for Medicine.
Summary
This year's Nobel Laureate discovered and elucidated mechanisms underlying
autophagy, a fundamental process for degrading and recycling cellular components.
Disruption of intracellular transport shown to trigger Alzheimer's disease Genetic risk factors shed light on causes of dementia
October 3, 2016 | University of Tokyo| A group of researchers at the University of Tokyo and their collaborators have found that genetic risk factors for Alzheimer's disease regulate the intracellular transport of enzymes responsible for the production of amyloid-β (Aβ), and that disruption of this transport mechanism triggers the onset of the disease.
Introducing the UPS® Members Benefit Program for Life Sciences BC Members
Take advantage of the UPS Members Benefit Program and save on a variety of UPS services! You'll receive 30% off small package shipments within Canada, to the U.S. and to worldwide destinations, 25% off imports into Canada, discounts starting at 70% off freight shipments and more.
Through your Life Sciences BC membership, you can save 10%-20% off the web price of wide range of office supplies from Grand & Toy! Plus, there is no charge for next-business-day delivery on orders over $50 to most Canadian locations. (Some conditions apply.)
Corporate discounts & group rates at The Listel Hotel
The Listel Hotel, a four star boutique hotel, is known for its enthusiastic service and commitment to high design and guest comfort. This intimate Robson street hotel boasts a perfect location with an award-winning restaurant Forage and gastro-pub Timber.
LSBC EVENTS
MEMBER NEWS
INDUSTRY NEWS
IN THIS ISSUE
HEALTH NEWS
JOB LINKS
